Serum fibroblast growth factor 19 (FGF19) levels are associated with atherogenic dyslipidemia in patients with type 2 diabetes.

ABSTRACT:

SUBMITTER: Hu JY 

PROVIDER: S-EPMC8478367 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature